Nextgen Biomed Ltd
Symbol: NXGN.TA
TLV
101.8
ILAMarket price today
-106.3909
P/E Ratio
0.0000
PEG Ratio
7.56M
MRK Cap
- 0.00%
DIV Yield
Nextgen Biomed Ltd (NXGN-TA) Stock Price & Analysis
Shares Outstanding
7.43M
Gross Profit Margin
0.00%
Operating Profit Margin
0.00%
Net Profit Margin
0.00%
Return on Assets
-0.54%
Return on Equity
-0.61%
Return on Capital Employed
-0.16%
Company general description and statistics
General Outlook
Return on Investments
Stock Prices
Liquidity Ratios
Analyzing NXGN.TA liquidity ratios reveals its financial health of the firm. The current ratio of 201.67% gauges short-term asset coverage for liabilities. The quick ratio (177.50%) assesses immediate liquidity, while the cash ratio (176.36%) indicates cash reserves.
cards.indicator | cards.value |
Current Ratio | 201.67% |
Quick Ratio | 177.50% |
Cash Ratio | 176.36% |
Profitability Ratios
The effective tax rate stands at 0.03%, revealing its tax efficiency. The net income per EBT, 99.97%, and the EBT per EBIT, 370.18%, provide insights into its earnings hierarchy.
cards.indicator | cards.value |
Effective Tax Rate | 0.03% |
Net Income per EBT | 99.97% |
EBT per EBIT | 370.18% |
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 2.02, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations.
cards.indicator | cards.value |
Days of Sales Outstanding | 178 |
Days of Payables Outstanding | 7227 |
Payables Turnover | 0.05 |
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.20, and free cash flow per share, -0.20, depict cash generation on a per-share basis. The cash per share value, 0.32, showcases liquidity position.
cards.indicator | cards.value |
Operating Cash Flow per Share | -0.20 |
Free Cash Flow per Share | -0.20 |
Cash per Share | 0.32 |
Free Cash Flow to Operating Cash Flow Ratio | 1.00 |
Per Share Data
Net income per share, -0.20, reflects the portion of profit attributed to each share. The book value per share, 0.29, represents the net asset value distributed per share, while the tangible book value per share, 0.28, excludes intangible assets.
cards.indicator | cards.value |
Net Income Per Share | -0.20 |
Book Value Per Share | 0.29 |
Tangible Book Value Per Share | 0.28 |
Shareholders Equity Per Share | 0.29 |
Growth Ratios
EBIT growth, -228.62%, and operating income growth, -228.62%, offer insights into operational profitability progression. The net income growth, -236.16%, showcases bottom-line expansion, and the EPS growth, -211.04%, measures the growth in earnings per share.
cards.indicator | cards.value |
EBIT Growth | -228.62% |
Operating Income Growth | -228.62% |
Net Income Growth | -236.16% |
EPS Growth | -211.04% |
EPS Diluted Growth | -211.04% |
Weighted Average Shares Growth | 9.26% |
Weighted Average Shares Diluted Growth | 9.26% |
Operating Cash Flow Growth | -3.57% |
Free Cash Flow Growth | 12.82% |
10-Year Operating CF Growth per Share | 87.08% |
5-Year Operating CF Growth per Share | -10.86% |
3-Year Operating CF Growth per Share | -60.68% |
10-Year Net Income Growth per Share | 94.10% |
5-Year Net Income Growth per Share | -282.49% |
3-Year Net Income Growth per Share | -372.28% |
5-Year Shareholders Equity Growth per Share | 120.53% |
3-Year Shareholders Equity Growth per Share | 550.50% |
Asset Growth | -36.99% |
Book Value per Share Growth | -45.63% |
R&D Expense Growth | 29.63% |
SGA Expenses Growth | -18.02% |
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 166,680,377.062, captures the company's total value, considering both debt and equity. Income quality, 0.32, assesses the reliability of reported earnings.
cards.indicator | cards.value |
Enterprise Value | 166,680,377.062 |
Income Quality | 0.32 |
Intangibles to Total Assets | 10.42% |
Graham Number | 1.13 |
Return on Tangible Assets | -64.28% |
Graham Net Net | 0.06 |
Working Capital | 3,993,000 |
Tangible Asset Value | 10,698,000 |
Net Current Asset Value | 2,614,000 |
Average Payables | 154,000 |
ROIC | -82.45% |
ROE | -0.69% |
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 71.61, and the price to book ratio, 71.61, reflect the market's valuation relative to the company's book value. Ratios like price to free cash flows, -5.23, and price to operating cash flows, -508.28, gauge market valuation against cash flow metrics.
cards.indicator | cards.value |
Price Book Value Ratio | 71.61 |
Price to Book Ratio | 71.61 |
Price Cash Flow Ratio | -508.28 |
Enterprise Value Multiple | -5.31 |
Price Fair Value | 71.61 |
Price to Operating Cash Flow Ratio | -508.28 |
Price to Free Cash Flows Ratio | -5.23 |
Price to Tangible Book Ratio | 13.91 |
Enterprise Value Over EBITDA | -19.59 |
EV to Operating Cash Flow | -60.54 |
Earnings Yield | -4.99% |
Free Cash Flow Yield | -1.60% |
Frequently Asked Question
How many company shares are outstanding in 2024?
There are stock number shares outstanding of Nextgen Biomed Ltd (NXGN.TA) on the TLV in 2024.
What is P/E ratio of enterprise in 2024?
The current P/E ratio of enterprise is -106.391 in 2024.
What is the ticker symbol of Nextgen Biomed Ltd stock?
The ticker symbol of Nextgen Biomed Ltd stock is NXGN.TA.
What is company IPO date?
IPO date of Nextgen Biomed Ltd is 2002-08-12.
What is company current share price?
Current share price is 101.800 ILA.
What is stock market cap today?
The market cap of stock today is 7564330.000.
What is PEG ratio in 2024?
The current 0.000 is 0.000 in 2024.
What is the number of employees in 2024?
In 2024 the company has 15.